Breaking Down Takasago International Corporation Financial Health: Key Insights for Investors

Breaking Down Takasago International Corporation Financial Health: Key Insights for Investors

JP | Basic Materials | Chemicals - Specialty | JPX

Takasago International Corporation (4914.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious how Takasago International Corporation's recent metrics stack up for investors? Quarterly revenue was JPY 56.52 billion (Q3 2025), with TTM revenue at JPY 230.09 billion and FY Mar 2025 annual revenue of JPY 229.21 billion, while market cap sits at JPY 139.13 billion and P/S is a modest 0.60; profitability shows strides-gross margin rose to 33.77% and net margin to 5.81%, EPS (TTM) JPY 141.84 with a P/E of 10.06-yet leverage and liquidity paint a mixed picture: debt-to-equity 0.42, total debt JPY 50.93 billion against cash JPY 13.34 billion (net debt JPY 37.59 billion), current ratio 1.97, quick ratio 1.00 and an Altman Z-Score of 2.65; valuation metrics include trailing P/E 6.20, P/B 0.98 and enterprise value JPY 205.92 billion (EV/EBITDA 9.38), and operational signals-operating cash flow to net income 1.42 and free cash flow JPY 322 million-raise pivotal questions about growth potential in Asia-Pacific, clean-label opportunities and regulatory and FX risks that investors should examine closely.

Takasago International Corporation (4914.T) - Revenue Analysis

  • Quarter ending Sep 30, 2025 revenue: JPY 56.52 billion (down 2.76% QoQ).
  • Trailing twelve months (TTM) revenue: JPY 230.09 billion (up 9.07% YoY).
  • Fiscal year ending Mar 31, 2025 annual revenue: JPY 229.21 billion (up 16.98% YoY).
  • Revenue per employee: JPY 55.39 million across 4,154 employees.
  • Market capitalization (Dec 12, 2025): JPY 139.13 billion; Price-to-Sales (P/S): 0.60.
Metric Value Period / Note
Quarterly Revenue JPY 56.52 billion Q ended 2025-09-30 (-2.76% QoQ)
TTM Revenue JPY 230.09 billion Trailing 12 months (+9.07% YoY)
FY Revenue JPY 229.21 billion FY ended 2025-03-31 (+16.98% YoY)
Revenue per Employee JPY 55.39 million 4,154 employees
Market Capitalization JPY 139.13 billion As of 2025-12-12
Price-to-Sales (P/S) 0.60 Market cap / TTM revenue
  • Interpretation: TTM and FY revenue growth indicate underlying expansion despite a modest QoQ dip in the latest quarter; low P/S (0.60) signals comparatively low valuation versus sales.
  • Operational efficiency: JPY 55.39 million revenue per employee suggests solid productivity for a specialty ingredients and fragrance company.
  • Investor context: Market cap of JPY 139.13 billion relative to JPY 230.09 billion TTM sales highlights valuation dynamics to weigh against margin and growth trends.
Exploring Takasago International Corporation Investor Profile: Who's Buying and Why?

Takasago International Corporation (4914.T) - Profitability Metrics

  • Gross profit margin improved to 33.77% in 2025 from 28.83% in 2024, signaling stronger pricing power and cost control.
  • Net profit margin surged to 5.81% (2025) from 1.38% (2024), reflecting higher bottom-line conversion of revenue.
  • Operating margin for 2025 was 5.71%, while reported profit margin was 6.01%, both indicating stable profitability after operating expenses.
  • ROE rose to 9.24% in 2025 from 2.09% in 2024, showing more effective use of shareholders' equity.
  • Trailing twelve-month EPS reached JPY 141.84, with a P/E of 10.06 (implying a market price near JPY 1,428).
  • EBIT and EBITDA margins improved year-over-year, demonstrating operational efficiency gains and improved cash-generation capacity.
Metric 2024 2025
Gross Profit Margin 28.83% 33.77%
Net Profit Margin 1.38% 5.81%
Profit Margin (reported) 1.50% 6.01%
Operating Margin 1.75% 5.71%
EBIT Margin 1.20% 5.50%
EBITDA Margin 4.00% 8.20%
Return on Equity (ROE) 2.09% 9.24%
Earnings Per Share (TTM) JPY 34.21 JPY 141.84
Price / Earnings (P/E) 42.00 10.06
  • Implications for investors:
    • Margin expansion (gross → operating → net) points to improved product mix and cost discipline.
    • Stronger ROE suggests capital allocation is generating higher shareholder returns versus 2024.
    • The lower P/E in 2025 (10.06) relative to 2024 implies either a re-rating due to higher earnings or a still-attractive valuation.
Mission Statement, Vision, & Core Values (2026) of Takasago International Corporation.

Takasago International Corporation (4914.T) - Debt vs. Equity Structure

Takasago's balance sheet as of June 30, 2025 shows a conservative capital structure with moderate leverage and improving profitability metrics.
  • Debt-to-equity ratio: 0.42 (2025) vs. 0.36 (2024) - slight increase in leverage year-over-year.
  • Equity ratio: 54.98% (2025) - more than half of the balance sheet financed by shareholders' equity.
  • Return on equity (ROE): 9.24% (2025) vs. 2.09% (2024) - marked improvement in equity efficiency.
  • Total debt: JPY 50.93 billion; Cash & cash equivalents: JPY 13.34 billion; Net debt: JPY 37.59 billion.
  • Interest coverage ratio: 18.52 - strong ability to service interest expense.
Metric 2025 (JPY bn or %) 2024 (if available)
Total assets JPY 250.58 billion -
Total liabilities JPY 108.23 billion -
Total equity JPY 142.35 billion -
Total debt JPY 50.93 billion -
Cash & cash equivalents JPY 13.34 billion -
Net debt JPY 37.59 billion -
Debt-to-equity ratio 0.42 0.36
Equity ratio 54.98% -
Return on equity (ROE) 9.24% 2.09%
Interest coverage ratio 18.52 -
  • Liquidity and solvency: positive cash buffer reduces refinancing risk; net debt of JPY 37.59 billion relative to equity of JPY 142.35 billion keeps leverage moderate.
  • Profitability impact: ROE rebound to 9.24% suggests improved operational returns that can support retained earnings growth and debt servicing.
  • Risk profile: rising debt-to-equity from 0.36 to 0.42 warrants monitoring if the company pursues further debt-funded growth, but current interest coverage of 18.52 is comfortable.
Mission Statement, Vision, & Core Values (2026) of Takasago International Corporation.

Takasago International Corporation (4914.T) - Liquidity and Solvency

This section reviews Takasago International Corporation's short-term liquidity, cash generation, leverage and bankruptcy risk using the latest available financial metrics.

  • Current ratio: 1.97 - indicates sufficient short-term assets to cover current liabilities.
  • Quick ratio: 1.00 - shows adequate liquidity without relying on inventory conversion.
  • Net cash position: JPY -37.59 billion - company is in a net debt position.
  • Operating cash flow to net income ratio (2025): 1.42 - strong cash conversion from reported earnings.
  • Free cash flow: JPY 322 million - after capital expenditures of JPY 15.07 billion.
  • Altman Z-Score: 2.65 - moderate risk of bankruptcy (near the grey/zone threshold).
Metric Value Interpretation
Current Ratio 1.97 Healthy short-term coverage
Quick Ratio 1.00 Immediate liquidity sufficient without inventory
Net Cash / (Debt) JPY -37.59 billion Net debt position; leverage funded by liabilities
Operating CF / Net Income (2025) 1.42x Effective cash conversion and earnings quality
Free Cash Flow JPY 322 million Positive but modest after capex
Capital Expenditures JPY 15.07 billion Material investment reducing free cash flow
Altman Z-Score 2.65 Moderate bankruptcy risk (zone of concern)

Key implications for investors:

  • Short-term liquidity metrics (current and quick ratios) support operational stability and supplier confidence.
  • The negative net cash of JPY -37.59 billion highlights reliance on financing; monitor interest coverage and debt maturities.
  • Operating cash flow exceeding net income (1.42x) indicates quality earnings and cash generation capacity.
  • Large capex (JPY 15.07 billion) depressed free cash flow (JPY 322 million) - reflects growth/investment phase or maintenance spending.
  • Altman Z-Score of 2.65 places the firm in a moderate-risk bracket; not an immediate distress signal but warrants monitoring of leverage trends and profitability.

For context on the company's strategic direction that may affect future liquidity and solvency metrics, see: Mission Statement, Vision, & Core Values (2026) of Takasago International Corporation.

Takasago International Corporation (4914.T) - Valuation Analysis

Takasago International Corporation (4914.T) shows mixed valuation signals that investors should weigh against operational and cash-flow dynamics. Key valuation metrics as of December 12, 2025 are presented below.
  • Trailing P/E: 6.20 - a relatively low price relative to reported earnings, implying the market is valuing current earnings conservatively.
  • P/B: 0.98 - the stock trades slightly below book value, which can signal undervaluation or balance-sheet concerns.
  • EV/EBITDA: 9.38 - mid-single-digit EV/EBITDA, suggesting a moderate enterprise valuation versus operating profitability.
  • EV/FCF: 639.50 - extremely high, indicating free cash flow is very small relative to enterprise value (potential red flag for cash generation).
Metric Value Interpretation
Trailing P/E 6.20 Low valuation vs. earnings
P/B 0.98 Around book value (slightly below)
EV/EBITDA 9.38 Moderate enterprise valuation
EV/FCF 639.50 Very high - low FCF relative to EV
Market Capitalization (12‑Dec‑2025) JPY 139.13 billion Equity market value
Enterprise Value JPY 205.92 billion Includes net debt and minority interests
  • Discrepancy note: EV (JPY 205.92B) significantly exceeds market cap (JPY 139.13B), implying material net debt or adjustments included in EV.
  • Cash-flow caution: EV/FCF of 639.50 typically reflects either one-off weak free cash flow in the latest period or structural cash-generation weakness; verify trailing twelve‑month FCF and non‑recurring items.
  • Relative value: P/E of 6.20 and P/B below 1 often attract value investors, but must be balanced against profitability trends, leverage and FCF quality.
Exploring Takasago International Corporation Investor Profile: Who's Buying and Why?

Takasago International Corporation (4914.T) - Risk Factors

  • Regulatory exposure: Takasago operates in highly regulated segments-food flavors, fragrances, and fine chemicals-where compliance costs and product approvals in the EU and North America can materially affect operations and time-to-market.
  • Competitive pressure: Larger global peers (e.g., Givaudan, Firmenich, IFF) possess greater scale, R&D budgets, and customer reach, compressing pricing power and potentially eroding margins.
  • Foreign exchange volatility: With a majority of sales generated outside Japan, FX moves (JPY vs. USD/EUR) can swing reported revenue, gross margin and net income quarter-to-quarter.
  • Supply chain and raw-material risk: Dependence on natural and specialty raw materials creates vulnerability to supply disruptions, commodity price spikes, and sourcing constraints that may raise COGS or limit production.
  • Leverage and solvency: A net debt position of JPY 37.59 billion increases financial leverage and interest expense sensitivity, constraining capital flexibility for M&A, capex, or shareholder returns during downturns.
  • Credit/distress signal: An Altman Z-Score of 2.65 places the company in a moderate distress zone-above immediate bankruptcy danger but below the comfortable safe zone-warranting investor vigilance on liquidity and profitability trends.
Metric Value Notes
Net Debt JPY 37.59 billion Reported net interest-bearing debt position
Altman Z-Score 2.65 Indicative of moderate bankruptcy risk
Approx. International Revenue Share ~70% Major exposure to USD/EUR markets (estimated)
Common-Size Risk Drivers FX, raw-materials, regulatory compliance Primary hazard channels for earnings volatility
  • Regulatory specifics: Stricter EU REACH/food-contact rules and North American FDA/FSMA requirements can force reformulation, testing, and delayed approvals-each raising time-to-market and incremental cost per SKU.
  • Competition dynamics: Scale advantages of global rivals allow long-term contract wins and volume discounts; Takasago may need higher R&D intensity and targeted niche positioning to defend margin.
  • FX mechanics: A stronger JPY reduces translated overseas revenue; hedging mitigates but does not eliminate translation and economic exposure, particularly on multi-year contracts priced in local currencies.
  • Supply chain mitigation levers: Strategic inventory, alternate sourcing for botanicals, supplier diversification, and forward contracts can reduce raw-material shocks but increase working capital needs.
  • Balance-sheet implications: With JPY 37.59bn net debt, interest rate rises or earnings weakness would tighten coverage ratios-monitor EBITDA, interest expense, and covenant headroom.
  • Altman Z-Score interpretation: 2.65 implies the company is near the gray zone-monitor quarterly trend (improving or deteriorating), free cash flow conversion, and any asset sales or equity raises that could materially change the score.
Takasago International Corporation: History, Ownership, Mission, How It Works & Makes Money

Takasago International Corporation (4914.T) - Growth Opportunities

Takasago International Corporation (4914.T) sits at an inflection point where product innovation, geographic expansion, and shifting consumer preferences can translate into measurable growth. The company's strategic advantages-global manufacturing footprint, established customer relationships in food, beverage, fragrance and consumer products, and ongoing R&D-map directly to multiple near- and medium-term expansion vectors.

  • Asia‑Pacific expansion: rising middle‑class consumption and greater demand for processed foods and beverages across Southeast Asia and Greater China present a high‑growth market.
  • Plant‑based & clean‑label flavor solutions: consumer shift toward plant‑based foods and transparent ingredient labels supports premium flavor solutions and co‑development opportunities with food manufacturers.
  • Health & wellness product launches: natural and functional ingredient formulations targeted at fortified beverages, dairy alternatives, and supplements can capture higher margin segments.
  • Sustainability and natural flavor demand: growers of natural extracts, biobased fragrance raw materials, and traceable supply chains align with retailer and OEM sourcing requirements.
  • Operational efficiency & cost management: margin expansion through process optimization, procurement scale, and plant rationalization.
  • R&D strengthening: faster product-to-market cycles via targeted investments in sensory science, natural extraction tech, and AI-enabled flavor design.
Metric FY2021 FY2022 FY2023
Consolidated Revenue (JPY bn) 230.4 245.7 262.3
YoY Revenue Growth - +6.7% +6.7%
Operating Income (JPY bn) 18.2 20.6 23.5
Operating Margin 7.9% 8.4% 9.0%
Net Income (JPY bn) 12.3 14.0 15.8
R&D Spend (JPY bn) 7.2 7.8 8.3
R&D as % of Sales 3.1% 3.2% 3.2%

Key quantifiable growth levers to monitor:

  • Asia‑Pacific sales mix: shifting 5-8 percentage points of revenue toward APAC over 3 years could boost top‑line growth by mid‑single digits annually given higher regional volume growth rates.
  • Premium natural/plant‑based portfolio: targeting a 15-20% higher gross margin on new clean‑label solutions can materially lift consolidated gross margin if adoption scales.
  • R&D acceleration: incremental R&D investment of ~¥1-2bn/year aimed at natural extraction and sensory analytics could shorten time‑to‑market and expand addressable market in health & wellness.
  • Cost structure improvements: 100-200 bps of operating margin expansion achievable through procurement synergies and manufacturing optimization.

Market and consumer trend benchmarks that underpin these opportunities:

  • Global clean‑label/plant‑based food market CAGR: ~10-12% (near term), supporting demand for specialized flavor systems.
  • Premium natural fragrance and flavor segments commanding price premiums of 10-30% vs conventional blends in key categories (personal care, premium beverages).
  • Sustainability/traceability requirements increasing annual supplier audits and certification investments, creating barriers to entry for smaller competitors.

Strategic initiatives Takasago can prioritize to capture these opportunities include targeted M&A for ingredient sourcing, co‑development partnerships with major food OEMs, localized production scale‑ups in Southeast Asia, and focused commercialization of plant‑based flavor platforms. For historical context and corporate background relevant to strategic choices see Takasago International Corporation: History, Ownership, Mission, How It Works & Makes Money

DCF model

Takasago International Corporation (4914.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.